Bionano Genomics, Inc. - Common Stock (NQ:BNGO)

1.445 -0.035 (-2.36%)

Delayed Quote Updated: 12:21 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bionano Genomics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Why Bionano Genomics Stock Continues To Surge ↗

October 05, 2022

Bionano Genomics Inc (NASDAQ: BNGO) shares continue to trade higher Wednesday after the company on Tuesday highlighted a study showing that optical genome mapping better detected structural variations...

Via Benzinga

11 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 05, 2022

Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 05, 2022

It's time for another overview of the biggest pre-market stock movers for Wednesday as we cover the news behind share movement this morning!

Via InvestorPlace

Why Vicinity Motor Is Trading Higher By Over 65%; Here Are 26 Stocks Moving Premarket ↗

October 05, 2022

Gainers Vicinity Motor Corp. (NASDAQ: VEV) rose 65.4% to $1.72 in pre-market trading. Vicinity Motor started deliveries of the first Class 3 electric truck to roll off the assembly line in Canada.

Via Benzinga

Recap: Bionano Genomics Q2 Earnings ↗

August 04, 2022

Bionano Genomics (NASDAQ:BNGO) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Bionano Genomic (BNGO) Stock Pops on Research Study ↗

August 02, 2022

Bionano Genomic is in the news today as a landmark research focusing on genomic mapping technology bolsters BNGO stock.

Via InvestorPlace

If You Invested $1,000 In BioNano (BNGO) Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now ↗

September 26, 2022

Investors who bought stocks during the COVID-19 market crash in 2020 have generally experienced some big gains in the past two years. But there is no question some big-name stocks performed better than...

Via Benzinga

7 Penny Stocks to Buy Now for Extraordinary Gains ↗

September 21, 2022

While most investors should probably stay away from penny stocks, for hardened gamblers, these ideas may carry upside potential.

Via InvestorPlace

5 Biotech Stocks Under $5: Bionano Genomics, Northwest BioTherapeutics Plus 3 More Stocks

September 15, 2022

September 15, 2022 – TheNewswire - The biotechnology industry comprises hundreds of public companies that are fusing biology with technology to develop novel drugs and new products to advance the...

Via TheNewswire.com

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 29, 2022

Via Benzinga

7 Hot Growth Stocks Poised to Triple by 2030 ↗

August 25, 2022

For multiple reasons, this looks like a wonderful time for investors to buy hot growth stocks with very strong outlooks.

Via InvestorPlace

Hold On to Bionano Genomics Stock Until It Reaches $6 at Least ↗

March 08, 2022

After a year of blockbuster revenue growth, BNGO stock deserves a major re-rating

Via InvestorPlace

Earnings Scheduled For March 1, 2022 ↗

March 01, 2022

Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated...

Via Benzinga

7 Cheap Penny Stocks to Buy Before They Boom ↗

August 19, 2022

If you have the stomach for extreme speculation, these cheap penny stocks to buy could move higher (but be ready for anything).

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 12, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

What In The World Is Going On With Bionano Genomics Shares? ↗

August 11, 2022

Bionano Genomics, Inc. (NASDAQ: BNGO) are trading higher by 11.8% to $3.36 Thursday afternoon. The company Thursday morning today announced the publication of the first study to evaluate the utility of...

Via Benzinga

Why Is Bionano Genomics (BNGO) Stock Up 20% Today? ↗

August 11, 2022

Bionano Genomics is in the news again, delivering groundbreaking nanoscale analytics research that has BNGO stock reaching for the stars.

Via InvestorPlace

Short Interest Sector Focus: Healthcare Sector ↗

July 29, 2022

As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

The 7 Best Stocks to Buy on a Dip in July ↗

July 14, 2022

With the stock market pricing in a recession that likely won't arrive anytime soon, these are some of the best stocks to buy on a dip.

Via InvestorPlace

3 Stocks That Could Double in 2022 ↗

June 08, 2022

With the market shaking off its downturn and the economy strengthening, there are several stocks that could double before the year is out.

Via InvestorPlace

Looking Into Bionano Genomics's Return On Capital Employed ↗

May 27, 2022

Bionano Genomics (NASDAQ:BNGO) brought in sales totaling $5.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 30.52%, resulting in a loss of $29.95 million.

Via Benzinga

7 Cheap Biotech Stocks to Buy Now ↗

May 19, 2022

These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.

Via InvestorPlace

Bionano Genomics's Earnings Outlook ↗

May 04, 2022

Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Bionano...

Via Benzinga

The Latest Studies by Bionano Genomics Are Promising, But It’s Not a Buy Yet ↗

April 11, 2022

BNGO stock has provided positive news from study results lately, but its fundamentals are not great and not a reason to invest in it now.

Via InvestorPlace

Why Bionano Genomics Stock Is Risky, but a Good Bet ↗

April 01, 2022

The risks may be clear when it comes to Bionano Genomics and BNGO stock. However, investors should see this as a long-term play.

Via InvestorPlace

Bionano Genomics Stock Can Regain the Crucial $5 Level ↗

March 22, 2022

Bionano Genomics is working hard to address rare diseases, yet Wall Street doesn't see the value in BNGO stock -- but that could change soon.

Via InvestorPlace

Bionano Genomics May Finally Offer a Reward for Your Risk ↗

March 18, 2022

BNGO stock has been a falling knife for the past year. But, with promising fundamentals and good tailwinds, now be the time to take a chance.

Via InvestorPlace

Bionano Genomics's Return On Capital Employed Insights ↗

March 04, 2022

Benzinga Pro data, Bionano Genomics (NASDAQ:BNGO) reported Q4 sales of $6.30 million. Earnings fell to a loss of $22.95 million, resulting in a 10.58% decrease from last quarter...

Via Benzinga

Bionano Genomics's Earnings Outlook ↗

February 28, 2022

Bionano Genomics (NASDAQ:BNGO) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.